Oteoarthrosis and osteoarthritis: from new viewpoints on the pathogenesis to a new name
https://doi.org/10.21518/2079-701X-2013-4-74-78
Abstract
The article tells about: pathogenesis and clinical picture of osteoarthritis (OA) caused by inflammatory processes and degeneration of the joint tissue; characteristic features of synovitis in OA based on ultrasound scanning; therapy of OA of the knee joint in the acute phase with Amelotex and Compligam B. The following clinical results were obtained: reduction of pain and swelling of the joint, increase of motion range and good tolerability of the drug.
Keywords
артроз,
артрит,
остеоартроз,
остеоартрит,
синовит,
Амелотекс,
Комплигам В,
arthrosis,
arthritis,
osteoarthrosis,
synovitis,
Amelotex,
Compligam B
About the Author
N. A. Khitrov
the Central Clinical Hospital and Polyclinic of the Presidential Administration of the Russian Federation, Moscow
Russian Federation
Russian Federation
References
1. Ревматические болезни: Рук. для врачей / под ред. В.А. Насоновой, Н.В. Бунчука. М.: Медицина, 1997. С. 385–396.
2. Raisz L.G. Prostaglandins and bone: physiology and pathophysiology. Osteoarthritis Cartilage, 1999. V. 79. P. 83—94.
3. Laufer S., Gay S., Brune K. Inflammation and Rheumatic Diseases: The molecular basis of novel therapies. Georg Thieme Verlag, 2003. 139 p.
4. Grushko G., Schneiderman R., Maroudas A. Some biochemical and biophysical parameters for the study of the pathogenesis of osteoarthritis: a comparison between the processes of aging and degeneration in human hip cartilage. Connec Tissue Res., 1989. V. 19. P 149—176.
5. Ревматология: национальное руководство / под ред. Е.Л. Насонова, В.А. Насоновой. М.: ГЭОТАР-Медиа, 2008 . С. 573–588.
6. Hedbom E., Huselmann H.J. Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell Mol Life Sci., 2002 . V. 59. P. 45—53.
7. Pickvance E.A., Oegema T.R. Jr., Thompson R.C. Immunolocalization of selected cytokines and proteases in canine articular cartilage after transarticular loading. J. Orthop. Res., 1993.- V. 113.- P. 313—323
8. Agarwal S., Long P., Seyedain A., et al. A central role for the nuclear factor-kB pathway in anti-inflammatory and proinflammatory actions of mechanical strain. FASEB J., 2003.- V. 17.- P. 899—901
9. Насонов Е.Л., Каратеев А.Е. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. Русский медицинский журнал, 2006.- Т. 14.- № 25.- С. 1769-1777
10. Feldman M., McMahon A.T. Do cyclooxigenase–2 inhibitors provide benefits similar to those of traditional nonsteroidal anti–inflammatory drugs, with less gastrointestinal toxicity? Ann. Intern. Med., 2000.- V. 132.- P. 134–143
11. Цветкова Е.С., Панасюк Е.Ю., Иониченок Н.Г., Рубцов О.В. Перспективы применения ингибиторов циклооксигеназы–2 при остеоартрозе. Consilium medicum, 2004, Т. 6.- №2.- С. 100
12. Каратеев А.Е., Барскова В.Г. Критерии выбора нестероидного противовоспалительного препарата. Справочник практического врача, 2007.- Т. 5.- № 5.- С. 13-17
Review
For citations:
Khitrov NA. Oteoarthrosis and osteoarthritis: from new viewpoints on the pathogenesis to a new name. Meditsinskiy sovet = Medical Council. 2013;(4):74-78. (In Russ.) https://doi.org/10.21518/2079-701X-2013-4-74-78
Views:
550
Email this article 